Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider has learned.
23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations ...
When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...
It also accused 23andMe of neglecting to notify certain users that data from people with Chinese or Ashkenazi Jewish heritage ...
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...
23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...
The 23andMe Health + Ancestry Personal Genetic DNA Test offers just that — an opportunity to kickstart these goals by providing valuable insights into your genetic makeup and ancestral origins.
Two of the most popular brands are Ancestry and 23andMe. To learn more, we outlined the pros, cons and factors to consider. However, since this comparison was first published, 23andMe has ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a data breach last year that specifically targeted customers of Ashkenazi Jewish ...
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...